Skip to main content
SpringerLink
Log in

Rationale for Established Antihypertensive Treatment

  • Conference paper
Primary Hypertension

  • 67 Accesses

Abstract

Medical science organizations and experts have repeatedly drawn up recommenda-tions for antihypertensive drug therapy. The currently valid stepped-care approach of the American Joint National Committee on Detection, Evaluation and Treatment of High Blood Pressure [15] and the German League against Hypertension [3] agree in recommending diuretics and beta blockers as the treatment of choice in hypertension. The question arises: What are the criteria that should be applied for selecting the initial antihypertensive agents and for the sequence of combining such drugs?

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berglund G, Wilhelmsen L, Sannerstedt R, Hansson L, Andersson O, Sivertsson R, Wedel H, Wikstrand J (1978) Coronary heart disease after treatment of hypertension. Lancet 1: 1–5

    Article  PubMed  CAS  Google Scholar 

  2. Bock KD, Anlauf M (1984) Die Qual der Wahl - das Dilemma der Hochdrucktherapie. Munch Med Wochenschr 126: 477–479

    Google Scholar 

  3. Deutsche Liga zur Bekämpfung des hohen Blutdruckes (1984) Empfehlungen zur Hochdruck-behandlung in der Praxis und zur Behandlung hypertensiver Notfalle, 6th edn. DLBHB, Heidelberg

    Google Scholar 

  4. Helgeland A (1980) Treatment of mild hypertension: a five-year controlled drug trial. The Oslo study. Am J Med 69: 725–732

    Article  PubMed  CAS  Google Scholar 

  5. Holme I, Helgeland A, Hjermann I, Leren P, Lund-Larsen PG (1984) Treatment of mild hyper-tension with diuretics. The importance of ECG abnormalities in the Oslo study and in MRFIT., JAMA 251: 1298–1299

    Google Scholar 

  6. Hypertension Detection and Follow-up Program Cooperative Group (1979) Five-year findings of the hypertension detection and follow-up program. I. Reduction in mortality of persons with high blood pressure, including mild hypertension. JAMA 242: 2562–2571

    Article  Google Scholar 

  7. Hypertension Detection and Follow-up Program Cooperative Group (1979) Five-year findings of the hypertension detection and follow-up program. II. Mortality by race-sex and age. JAMA 242: 2572–2577

    Article  Google Scholar 

  8. Hypertension Detection and Follow-up Program Cooperative Group (1982) The effect of treatment on mortality in “mild” hypertension. Results of the hypertension detection and follow-up program., N Engl J Med 307: 976–980

    Article  Google Scholar 

  9. Hypertension Detection and Follow-up Program Cooperative Research Group (1984) The effect of antihypertensive drug treatment on mortality in the presence of resting electrocardiographic abnormalities at baseline: the HDFP experience. Circulation 70: 996–1003

    Article  Google Scholar 

  10. Multiple Risk Factor Intervention Trial Research Group (1982) Multiple-risk factor intervention trial: Risk factor changes and mortality results. JAMA 248: 1465–1477

    Article  Google Scholar 

  11. Report by the Management Committee (1980) The Australian therapeutic trial in mild hypertension. Lancet 2: 1261–1267

    Google Scholar 

  12. Report of Medical Research Council Working Party on Mild to Moderate Hypertension (1977) Randomized controlled trial of treatment for mild hypertension: design and pilot trial. Br Med J 1: 1437–1440

    Article  Google Scholar 

  13. Report of Medical Research Council Working Party on Mild to Moderate Hypertension (1981) Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Lancet 3: 539–543

    Google Scholar 

  14. The IPPPSH Collaborative Group (1984) The international prospective primary prevention study in hypertension (IPPPSH): objectives and methods. Eur J Clin Pharmacol 27: 379–391

    Article  Google Scholar 

  15. The Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (1984) The 1984 report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 144: 1045–1057

    Google Scholar 

  16. United States Public Health Service Hospitals Cooperative Study Group (1977) Treatment of mild hypertension. Results of a ten-year intervention trial., Circ Res [Suppl I] 40: 98–105

    Google Scholar 

  17. Veterans Administration Cooperative Study Group on Antihypertensive Agents (1970) Effects of treatment on morbidity in hypertension. II. Results in patients with diastolic blood pressure averaging 90 through 114mmHg. JAMA 213: 1143–1152

    Article  Google Scholar 

  18. Veterans Administration Cooperative Study Group on Antihypertensive Agents (1977) Pro-pranolol in the treatment of essential hypertension. JAMA 237: 2303–2310

    Article  Google Scholar 

  19. Veterans Administration Cooperative Study Group on Antihypertensive Agents (1982) Comparison of propranolol and hydrochlorothiazide for the initial treatment of hypertension: II. Results of long-term therapy., JAMA 248: 2004–2011

    Article  Google Scholar 

  20. Wilhelmsen L, Berglund G, Elmfeldt D, Wedel H (1981) p-Blockers versus saluretics in hypertension. Comparison of total mortality, myocardial infarction, and sudden death: study design and early results on blood pressure reduction. Prev Med 10: 38–49

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medizinische Poliklinik, Universität München, Pettenkoferstr. 8a, D-8000, München 2, Germany

    H. Holzgreve & M. Middeke

Authors
  1. H. Holzgreve
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Middeke
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Internal Medicine II, Merheim Hospital and Policlinic of the University of Cologne, Ostmerheimer Str. 200, D-5000, Köln 91, Germany

    Werner Kaufmann , Gerd Bönner , Robert Lang  & Karl August Meurer , ,  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Holzgreve, H., Middeke, M. (1986). Rationale for Established Antihypertensive Treatment. In: Kaufmann, W., Bönner, G., Lang, R., Meurer, K.A. (eds) Primary Hypertension. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-71125-1_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-71125-1_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-16390-9

  • Online ISBN: 978-3-642-71125-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation